Affordable, early detection of viruses
Backed by MIT and Harvard scientists. Designed to be fast and accurate.
COVID – 19
Is it just a cough or should we test for coronavirus? Limited number of tests available makes doctors more likely to prioritise.
When an outbreak starts hospitals and labs become overwhelmed in no time.
Outbreak prediction can be a reality.
E25Bio’s Platform Technology
01
Antibody discovery for target X
02
Rapid diagnostic test development
03
Mobile phone app image capture
04
Outbreak monitoring
How is E25Bio’s RDT different from RT-PCR and ELISA tests?
- Rapid diagnosis during
acute, fever-phase - Specificity
- Sensitivity
- Procedure time
- Sample source
- Reagents
- Cold chain
- Price
E25BIO’S RAPID
DIAGNOSTIC TEST
- Yes
- 80-90% (High)
- > 90%
- < 10 min
- Blood and respiratory
- No
- No
- < $20/test
RT-PCR
- No
- High
- High
- > 180 min
- Serum
- Yes
- Yes
- +$100/test
ELISA
- No
- Mid
- Mid
- > 180 min
- Serum
- Yes
- No
- +$500/plate
State of the art – COVID 19 RDTs
E25Bio’s team of experts invented and are developing a rapid diagnostic test that is undergoing clinical trials for the coronavirus.
Backed by MIT scientists, they introduced an accurate, affordable, and fast testing solution meant to tackle the current outbreak which affects the global population – and whatever comes next. Just look at this map of how far SARS-CoV-2 spread.
